BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30013992)

  • 1. STAT5 and TET2 Cooperate to Regulate FOXP3-TSDR Demethylation in CD4
    Ma H; Gao W; Sun X; Wang W
    J Immunol Res; 2018; 2018():6985031. PubMed ID: 30013992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of Tet2 is associated with Foxp3 TSDR hypermethylation in regulatory T cell of allergic rhinitis.
    Tan L; Qiu T; Xiang R; Cao C; Deng Y; Tao Z; Xu Y
    Life Sci; 2020 Jan; 241():117101. PubMed ID: 31778687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mbd2 promotes foxp3 demethylation and T-regulatory-cell function.
    Wang L; Liu Y; Han R; Beier UH; Thomas RM; Wells AD; Hancock WW
    Mol Cell Biol; 2013 Oct; 33(20):4106-15. PubMed ID: 23979593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of Tet2 prevents TSDR demethylation in IL2 deficient regulatory T cells.
    Nair VS; Oh KI
    Biochem Biophys Res Commun; 2014 Jul; 450(1):918-24. PubMed ID: 24984151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis.
    Yang R; Qu C; Zhou Y; Konkel JE; Shi S; Liu Y; Chen C; Liu S; Liu D; Chen Y; Zandi E; Chen W; Zhou Y; Shi S
    Immunity; 2015 Aug; 43(2):251-63. PubMed ID: 26275994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs.
    Anderson MR; Enose-Akahata Y; Massoud R; Ngouth N; Tanaka Y; Oh U; Jacobson S
    J Neuroimmune Pharmacol; 2014 Sep; 9(4):522-32. PubMed ID: 24845974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disabled C3ar1/C5ar1 Signaling in Foxp3+ T Regulatory Cells Leads to TSDR Demethylation and Long-Term Stability.
    Medof ME; Rieder SA; Shevach EM
    J Immunol; 2023 Nov; 211(9):1359-1366. PubMed ID: 37756526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
    Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
    Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation controls Foxp3 gene expression.
    Polansky JK; Kretschmer K; Freyer J; Floess S; Garbe A; Baron U; Olek S; Hamann A; von Boehmer H; Huehn J
    Eur J Immunol; 2008 Jun; 38(6):1654-63. PubMed ID: 18493985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells.
    Wilk C; Effenberg L; Abberger H; Steenpass L; Hansen W; Zeschnigk M; Kirschning C; Buer J; Kehrmann J
    Cell Immunol; 2022 Jan; 371():104471. PubMed ID: 34954490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Methylation of FOXP3 (Forkhead Box P3)-TSDR (Regulatory T-Cell-Specific Demethylated Region) Is Associated With Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndrome.
    Zhu L; Jia L; Liu Z; Zhang Y; Wang J; Yuan Z; Hui R
    Hypertension; 2019 Sep; 74(3):581-589. PubMed ID: 31327269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells.
    Polansky JK; Schreiber L; Thelemann C; Ludwig L; Krüger M; Baumgrass R; Cording S; Floess S; Hamann A; Huehn J
    J Mol Med (Berl); 2010 Oct; 88(10):1029-40. PubMed ID: 20574810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted De-Methylation of the FOXP3-TSDR Is Sufficient to Induce Physiological FOXP3 Expression but Not a Functional Treg Phenotype.
    Kressler C; Gasparoni G; Nordström K; Hamo D; Salhab A; Dimitropoulos C; Tierling S; Reinke P; Volk HD; Walter J; Hamann A; Polansky JK
    Front Immunol; 2020; 11():609891. PubMed ID: 33488615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 5-aza-2'-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cells.
    Kehrmann J; Tatura R; Zeschnigk M; Probst-Kepper M; Geffers R; Steinmann J; Buer J
    Immunology; 2014 Jul; 142(3):384-95. PubMed ID: 24476360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival.
    Zhuo C; Li Z; Xu Y; Wang Y; Li Q; Peng J; Zheng H; Wu P; Li B; Cai S
    Mol Cancer; 2014 Jun; 13():153. PubMed ID: 24938080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 promotes the expansion of regulatory T cells via DNMT3a- and TET2- mediated Foxp3 expression in sepsis.
    Zhang H; Wu T; Ren C; Dong N; Wu Y; Yao Y
    Burns Trauma; 2023; 11():tkad021. PubMed ID: 37564681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxP3 demethylation is increased in human colorectal cancer and rat cholangiocarcinoma tissue.
    Schultze FC; Andag R; Alwahsh SM; Toncheva D; Maslyankov S; Yaramov N; von Ahsen N; Brandhorst G; Walson PD; Oellerich M; Petrova DT
    Clin Biochem; 2014 Feb; 47(3):201-5. PubMed ID: 24291052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance.
    Braza F; Dugast E; Panov I; Paul C; Vogt K; Pallier A; Chesneau M; Baron D; Guerif P; Lei H; Laplaud DA; Volk HD; Degauque N; Giral M; Soulillou JP; Sawitzki B; Brouard S
    J Am Soc Nephrol; 2015 Aug; 26(8):1795-805. PubMed ID: 25556168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of CD4
    Khosravi M; Bidmeshkipour A; Cohen JL; Moravej A; Hojjat-Assari S; Naserian S; Karimi MH
    Stem Cell Res Ther; 2018 Oct; 9(1):273. PubMed ID: 30359308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.
    Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B
    Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.